Veterinary Dermatology Drugs Market - By Drug Class (Antibacterial, Antifungal, Antiparasitic) Indication (Parasitic, Autoimmune), Route of Administration (Topical, Oral), Animal (Companion, Livestock), Distribution Channel, Global Forecast (2023 – 2032)

Published Date: July - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Veterinary Dermatology Drugs Market - By Drug Class (Antibacterial, Antifungal, Antiparasitic) Indication (Parasitic, Autoimmune), Route of Administration (Topical, Oral), Animal (Companion, Livestock), Distribution Channel, Global Forecast (2023 – 2032)

Veterinary Dermatology Drugs Market Size

Veterinary Dermatology Drugs Market size was valued to be USD 7.3 billion in 2022 and is expected to reach USD 18.1 billion in 2032 with a CAGR of 9.5% from 2023 to 2032. The rising incidence of skin disorders in animals, increasing medicalization rate, and increasing spending on animal healthcare are projected to drive market growth.

To get key market trends

  Download Free Sample

The rising trend of pet ownership across the globe has led to a growing demand for veterinary pharmaceuticals, including dermatology drugs. Skin problems are common in pets, and the prevalence of dermatological conditions such as allergies, infections, and parasitic infestations has been increasing. As more people consider their pets as family members, they are willing to invest in their well-being and healthcare, leading to an increased demand for dermatology drugs for various skin conditions.
 

Veterinary Dermatology Drugs Market Report Attributes
Report Attribute Details
Base Year 2022
Veterinary Dermatology Drugs Market Size in 2022 USD 7.3 Billion
Forecast Period 2023 to 2032
Forecast Period 2023 to 2032 CAGR 9.5%
2032 Value Projection USD 18.1 Billion
Historical Data for 2018 to 2022
No. of Pages 248
Tables, Charts & Figures 431
Segments covered Drug class, Indication, Route of Administration, Animal Type, Distribution Channel, and Region
Growth Drivers
  • Increasing pet ownership
  • Rising incidence of dermatological diseases
  • Technological advancements in veterinary dermatology
  • Increasing animal medicalization rates
  • Increasing number of veterinary dermatology practitioners
  • Increased spending on animal healthcare
  • Adverse side effects and safety concerns
Pitfalls & Challenges
  • High cost of drug development

What are the growth opportunities in this market?

 Download Free Sample

The pharmaceutical companies are investing in research and development of new and improved veterinary dermatology drugs. Advancements in drug formulations and modes of delivery are enhancing the effectiveness and ease of administering these medications.

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the veterinary dermatology drugs market. During the early stages of the pandemic, disruptions in global supply chains affected the availability and distribution of various pharmaceutical products, including veterinary drugs. This could have led to challenges in accessing certain veterinary dermatology drugs. In addition, many veterinary clinics had to implement safety measures such as social distancing and limited in-person appointments to reduce the risk of COVID-19 transmission. This may have affected the frequency of pet visits and consultations, leading to altered prescription patterns for veterinary dermatology drugs.

However, the pandemic influenced pet owner spending behaviour, with some focusing more on essential pet care needs and limiting non-urgent veterinary visits. This might have impacted the demand for certain veterinary dermatology drugs. Also, pandemic has led to an increase in pet adoptions and fostering in some countries such as U.S., UK, and Germany. This influx of new pet owners boosts the market size.

However, disruptions in supply chains resulting in medication shortages and reduction in number of patient visits due to lockdowns has significantly impacted the market. With the reduction in the number of coronavirus cases, the market is resuming its normal growth. 

Veterinary Dermatology Drugs Market Trends

Several trends were shaping the market includes the growing trend of pet humanization and increased awareness about pet health has led to a higher demand for specialized veterinary dermatology drugs, rising emphasis on preventive care, including dermatological health, increasing investments in research and development to improve drug formulations for veterinary dermatology, rising prevalence of allergies, such as atopic dermatitis, the increasing adoption of telemedicine and e-commerce in veterinary care, and rising adoption of pet insurance. These above factors are driving the market trends.

Veterinary Dermatology Drugs Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on drug class, the market is categorized into antifungal drugs, antibacterial drugs, antiparasitic drugs, and other drug classes. The antibacterial drugs segment held the largest market share of 38.0% in 2022. Bacterial skin infections are common in pets, particularly dogs and cats. Bacteria such as Staphylococcus spp., Streptococcus spp., and Pseudomonas spp. can cause these diseases. As bacterial skin infections are so common, there is a strong demand for effective antibacterial medications in veterinary dermatology.

Based on indication, the veterinary dermatology drugs market is categorized into parasitic infections, autoimmune skin diseases, allergic infections, skin cancer, and other indications. The parasitic infections segment held the largest market share of 33.3% in 2022. Parasitic infections are widespread in animals, and they can cause a range of skin problems, including dermatitis, itching, and hair loss. The high prevalence of parasitic infections drives the demand for animal parasiticides.

Learn more about the key segments shaping this market

 Download Free Sample

When it comes to treating skin conditions in pets, veterinarians have three main optionsinjections, topical creams, and oral medications. Out of these, oral medications are expected to be a big deal, with experts predicting that they'll be worth around 3.4 billion US dollars in 2022 and keep growing by about 9.2% each year until 2030. Why are oral meds so popular? Well, they can get into the bloodstream and target the root cause of the skin problem. Plus, they're easy to give to pets—just pop a pill in their mouth, and you're done! And because pets are more likely to take oral medications consistently, they're more effective in the long run.

Picture thisyou've got a furry friend at home, maybe a playful pup or a cuddly kitty. But what if they start scratching and itching like crazy? That's where veterinary dermatology drugs come in to save the day! These drugs are like magical potions for animals with skin problems. And just like there are different types of animals, there are different types of dermatology drugs for them. First, let's divide our animal friends into two groupsCompanion animalsThese are our furry pals who keep us company at home, like dogs, cats, and even horses. Livestock animals These are animals we raise for food or other purposes, like cows, pigs, and other farm animals. Now, guess which group has been using the most dermatology drugs? You got it—the companion animals! Why? Because more and more people are bringing pets into their homes. And as these furry friends become part of our families, we're spending more on their health, including skin medications. So, in the dermatology drug world, companion animals rule the roost with a massive 60.6% share. And they're only going to keep growing, with experts predicting a whopping 9.6% growth in the next few years. Why? Simple—we love our pets and we want them to be happy and healthy, skin and all!

Based on istribution channel, the veterinary dermatology drugs market is classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held dominant market share of around 56.5% in 2022. Hospital pharmacies stock a wide range of dermatology drugs to manage various skin issues in animals, including bacterial, fungal, and parasitic infections. The availability of these medications ensures timely and effective treatment of dermatological conditions.

Looking for region specific data?

 Download Free Sample

North America veterinary dermatology drugs market accounted for significant revenue in 2022 and is expected to reach USD 6.9 billion in 2032 with a CAGR of 9.3% from 2023-2032. North America has a significant number of veterinary dermatology specialists who focus on diagnosing and treating skin conditions in animals. The availability of specialized care drives the demand for specific dermatology drugs in the region. In addition, the region's strong research and development efforts in veterinary medicine have led to advancements in dermatology drugs. The introduction of new and improved formulations enhances the treatment options available for veterinarians.

Moreover, the trend of pet humanization, where pets are considered part of the family, is increasing in North America. Pet owners are willing to invest in their pets' health and well-being, leading to a higher demand for advanced veterinary dermatology drugs to address skin issues.

Veterinary Dermatology Drugs Market Share

There are several significant competitors in the highly competitive veterinary dermatology drugs companies. The prominent players are

  • Elanco Animal Health Incorporated
  • Vetoquinol S.A.
  • Ceva
  • Merck & Co., Inc.
  • Zoetis, Inc.
  • Virbac
  • Bimeda, Inc.
  • Vivaldis
  • Bioiberica S.A.U
  • Indian Immunologicals Ltd.

To keep a competitive advantage in the market, such companies are putting various tactics into practice, including partnerships, mergers, acquisitions, collaborations, and product launches.

Veterinary Dermatology Drugs Market Industry News

  • In March 2023, Zoetis announced the addition of two new applications to its Vetscan Imagyst multipurpose diagnostic platformone for AI dermatology and another for AI equine FEC analysis. The Vetscan Imagyst AI dermatology application analysis ear and skin swaps, impression smears, to detect yeast, bacteria, and inflammatory cells providing accurate results.
  • In January 2022, Percheron Capital has acquired the majority stake in Animal Dermatology Group, Inc. (ADG), a veterinary dermatology expert in the United States. With this acquisition, ADG's veterinary dermatology specialised services are now available in 12 states throughout the US.

The veterinary dermatology drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

 

 

Market Size, By Drug Class

 

  • Antibacterial drugs
  • Antifungal drugs
  • Antiparasitic drugs
  • Other drug classes

Market Size, By Indication

  • Parasitic infections
  • Allergic infections
  • Autoimmune skin diseases
  • Skin cancer
  • Other indications

Market Size, By Route of Administration

  • Injectable
  • Topical
  • Oral

Market Size, By Animal Type

  • Companion animal
    • Dogs
    • Cats
    • Horses
    • Other companion animals
  • Livestock animal
    • Bovine
    • Swine
    • Other livestock animals

Market Size, By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

The above information is provided for the following regions and countries

  • North America 
    • U.S.
    • Canada
  • Europe 
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific 
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America 
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa 
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

 

Related Reports

Table of Content

Will be Available in the sample /Final Report. Please ask our sales Team.

List Tables Figures

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email